The Scientist

» ebola and cell & molecular biology

Most Recent

image: Week in Review: November 10–14

Week in Review: November 10–14

By | November 14, 2014

Funding for African science; microbiome studies may have contamination worries; mind-controlled gene expression; DNA record keeper


image: Ebola Drug Trials to Start in Africa

Ebola Drug Trials to Start in Africa

By | November 13, 2014

Researchers will test antiviral drugs and transfusions of blood from Ebola survivors in the West African countries hardest hit by the epidemic.


image: Funding Research in Africa

Funding Research in Africa

By | November 12, 2014

The ongoing Ebola epidemic in West Africa is drawing more money to study the virus, but what about funding for African science in general?


image: Mapping the Human Proteome

Mapping the Human Proteome

By | November 10, 2014

A comprehensive map of human proteins throughout the body identifies the testes as home to the most unique blend of gene products.


image: Maps for Disease

Maps for Disease

By | November 10, 2014

A collaboration between Doctors Without Borders, the Red Cross, and other organizations aims to map developing cities across the globe to improve disease response efforts.


image: <em>TS</em> Picks: November 7, 2014

TS Picks: November 7, 2014

By | November 7, 2014

Trouble obtaining Ebola samples; Republicans take over Congressional science committees; postdoc participation


image: Ebola Edits Its Messages

Ebola Edits Its Messages

By | November 5, 2014

Deep sequencing of viral mRNAs reveals that Ebola and Marburg viruses produce multiple versions of some transcripts.


image: Taking Shots at Ebola

Taking Shots at Ebola

By | November 5, 2014

With an infusion of public and private resources and accelerated regulatory processes, a handful of companies are racing to develop a vaccine to curb the Ebola epidemic.


image: Rare Disease to Inform Ebola Susceptibility?

Rare Disease to Inform Ebola Susceptibility?

By | November 4, 2014

Parents of children with the fatal genetic disease Niemann-Pick Type C are taking an active role in research to understand how mutations associated with the disease may protect against Ebola.


image: Enhanced Enhancers

Enhanced Enhancers

By | November 1, 2014

The recent discovery of super-enhancers may offer new drug targets for a range of diseases.


Popular Now

  1. Genetic Test Solves Royal Mystery
    Notebook Genetic Test Solves Royal Mystery

    Genetic analyses lay to rest conspiracy theories about death of Belgian King Albert I, who lost his life in a rock climbing accident more than 80 years ago.

  2. Investigation Finds Pathologist Guilty of Systemic Misconduct
  3. Bacteria and Humans Have Been Swapping DNA for Millennia
  4. Opinion: Stop Submitting Papers